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CLINIC 
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I-123 me&aiodobenzylguanidine(MIBG) is a new ra 
ceutical agent that reflects sympathetic nerve f 
tXtIt myocardfal infaretion(AMI), greater defects are 
observed with MIBG than with Tl-201(Tl).In this study, 
simultaneous MIBG/Tl myocardial SPECT(M-S) was performed 
in 20 AM1 patient(pts) to compare with exercise myocardi- 
al SPECT(EX-S) and simultaneous 99m-Tc-PYP/Tl myocardial 
SPECT(PYP-S).M-S was feasible during acute(within 2 weeks 
of dLsease onset), subacute(within 2 months of onset) and 
chronic(2 months after onset or later) stages in 16, 15 
and 11 ptsr respectively. Por each ease, 20 segments of 
SPECT image were visually scored and a defect score(DS) 
was assigned. DS was greater with MIBG than with Tl, with 
respective mean Tl vs. MlBG DS being 17.7214.7 vs. 32.12 
17.9 in acute stage, 12.0$8.9 vs. 27.6+_30.6 in subacute 
stage and 11.2214.7 vs. 28.7215.2 in chronic stage(p6 
0.01). In 9 pts where a follow-up study was done, the mean 
MIBG DS was 3s.el4.9 vs. 30.1+11.7 vs. 25.9212.4 in each 
stage(the value for chronic stage was significantly 
smaller than that for acute stage, pcO.OS),In 17 cases in 
which DS was definitely greater with MIBG than with Tl(Tl/ 
MIBG ratio of DS 0.75)all showed EX-S evidence of lschemia 
In the AMI-affected area except for 3 pts with recanaliza- 
tion of infarct-related artery. Of these 17 ptsp PYP-S was 
performed in 10 pts and overlapping of Tc and Tl was noted 
in 9 pts. The denervated but viable myocardium after AM1 
was likely to be reinnervated during chronic stage. The 
dissociation of distribution between Tl and MIBG offered 
valuable information for formulating therapeutic policy. 
DIPYRIDAMOLE-VASODILATORY RESPONSE IN CARDIAC 
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We investigated myocardial blood flow ( 
transplanted (TX), denervated heart using dipyridamole 
(D)-induced vasodilatation. MBF was measured in 10 
nonrejecting TX pts with no angiographic evidence of 
coronary sclerosis 13-72 months after TX using 150-H20 
for PET dynamic imaging. Seven normal (K) volunteers 
served as a control group. Regional blBF was measured at 
rest (RI and after D infusion. ECG and BP were 
monitored to obtain double-product (DP). MBF values 
were obtained by fitting ??yocardial and arterial time 
activity curves to a 2 compartment tracer kinetic model. 
This method has been validated against gamma labelled 
microspheres in a dog model (r=0.97). Results are 
expressed in ml/g/min for MBF. 
R-MBF R-DP D-WBF D-DP 
TX 1.0210.20 11437+2881 1.98rO.48 1180242525 
N 0.79fD. 11 714621628 2.95i0.83 1053211692 
p (t-test) 0.011 0.0016 0.008 0.238 
The higher R-MBF observed in TX pts was proportionalLy 
related to a higher R-DP. There was no Significant 
increase (4%) In DP in TX pts and a 47% increase in N to 
D infusion. MBF increased 2 times the control VdW?S in 
TX pts. It is concluded that Tx pta have a higher 
resting MBF and a preserved vasodilatory response tQ 
dipyridamole, however smaller than that observed in 
N subjects. 
